Adult use
Small batch handcrafted cannabis grown organically by Canada’s leading cultivation team consistently delivering high levels of THC and CBD
UNITING THE WORLD THROUGH CANNABIS.
Experion is a Canadian licensed producer of premium cannabis focused on growing craft high quality strains within a state of the art facility skilled at maneuvering the regulatory environment, getting products into the market for distribution and building brand recognition. Is there opportunity? Plenty.
There has never been a better time:
-
Cannabis consumers are projected to spend U.S. $5.2 billion in Canada by 2024
-
The medical marijuana market in Canada has the potential to be U.S. $1.88 billion by 2025
-
Global cannabis spending is expected to reach U.S. $66.3 billion by the end of 2025
Current markets
(TSXV:EXP) (OTCQB:EXPFF)
-
$0.0550
CURRENT ($)
-
-0.01
24-hour Change ($)
-
-8.33%
24-hour Change (%)
Category Leading Brands For Everyone
-
Creating premium handcrafted cannabis products for all consumer needs
-
-
Therapeutic
Pills and topicals designed to mitigate chronic pain and improve user lifestyle so you can focus on what you care about
-
Medical
Direct to patient sales of high quality flower and CBD pills utilizing advanced encapsulation technology that delivers precise micro-dosing
An established and growing
global presence
We should mention not only the emerging markets here, but hopefully the partnerships already secured in those markets.
Experion advantages
State-of-the-art facilities, scientific research, and key partnerships give Experion the clear upper hand.
-
Advanced facility
Traditional growing in a GMP capable state of the art cultivation and processing facility supported by Canada's premier cultivation experts
-
Research
Developing a bank of over 60 genetic strains and administering Canada's first Stage 3 clinical trial for pain management with cannabis
-
Partnerships
Driving shareholder value through productive partnerships with only the best cannabis producers, discerning retailers and innovative manufacturers
-
Global export
Expertise, skill set and network to take advantage of global export opportunities
Press releases
-
Experion Increases Cultivation and Processing Capacity
March 30th, 2020
-
Experion Annual Filings Update
March 27th, 2020
-
Experion Expands National Distribution
March 23rd, 2020
-
Q1 2020 Strategic Update
February 20th, 2020
-
EXPERION SIGNS NON-BINDING TERM SHEET FOR UP TO $8.5 MILLION TERM LOAN FROM TRICHOME FINANCIAL, A LEADING CANNABIS FOCUSED INSTITUTIONAL INVESTOR
January 22nd, 2020
-
Experion Announces Returning Board Director
January 21st, 2020
Public filings
The numbers
-
$5.2B
Projected spend Adult-use cannabis in Canada by 2024 (USD)
-
$1.88B
Potential size of the Medical marijuana market in Canada by 2025 (USD)
-
$2.03B
Expected Canadian market size for alternative cannabis products annually starting 2020 (USD)
-
$66.3B
Global cannabis spend by the end of 2025 (USD)
THE KEY POINT
As the world continues to shift towards the legalization of cannabis, Experion has a unique advantage to distribute high quality flower and therapeutic products on a global platform
-
EXPANSION
Optimize cultivation and processing capacity internally and with grow partners
-
CATEGORY LEADING BRANDS
Expand distribution and deepen brand awareness
-
PRODUCT DEVELOPMENT
Develop continuous rotation of premium high-quality cannabis strains for launch
